Check out your Company Bowl for anonymous work chats.
To close out Asian American, Native Hawiaan, and Pacific Islander (AANHPI) Heritage Month, our Asian and Pacific Islander Community (APIC) ERG discussed the meaning of “home,” their diverse backgrounds and experiences, assimilation challenges, and how genetics has contributed to their identity. Thank you, Mithra K., Sr. Associate Scientist, Immuno-Oncology, and Angelo Ignacio, Email Marketing Manager, for hosting the panel of employees. The panel included Bo Yoo, Data Scientist; Kristina Pabayo, Director, Customer Care; Melissa Aphayrath, Associate Privacy Program Manager and Zayn Cochinwala, Research Operations Associate.
This week the 23andMe Speaker Series hosted a Keynote and Q&A session with Michael Specter, New Yorker science writer and author of “Higher Animals: Vaccines, Synthetic Biology, and the Future of Life.” In addition to speaking about and sharing clips from his audiobook, Michael discussed the journey of biology, from a purely physical science to a powerful new form of information and answered employee questions.
Our new Ancestry Composition update may provide more detail for customers with roots that trace back to Indigenous American ancestors from 28 different regions in what is now Mexico. This update is part of our continuing work to improve our reports and features and allows customers from these genetic groups to see their connections genetically and geographically. *This update is only for 23andMe customers on the latest genotyping platform, v5.
Introducing Austin Pate, our Senior Marketing Data Analyst at 23andMe! Austin's role focuses on email optimization and business operations. He is responsible for developing tests, conducting data marketing analysis, and identifying areas for improvement to increase consumer engagement. Austin also collaborates closely with the Data Engineering team, building data pipelines and creating tools for teams within 23andMe to explore the collected marketing data. When asked about his favorite part of working at 23andMe, Austin emphasized the people. "In addition to being some of the brightest folks out there, everyone I've come into contact with over my 5+ years has been friendly and willing to bring their expertise to the table in order to accomplish our common goals," he said.
Results from the Phase 1 portion of our First-in-Human Phase 1/2a clinical trial of 23ME-00610 were reported recently at the annual American Association for Cancer Research (AACR) meeting in Orlando. "We are pleased with the Phase 1 data," said Jennifer Low, MD, Ph.D., Head of Therapeutics Development at 23andMe. "The Phase 2a portion of the study is now underway, and we look forward to further evaluation."
This #MentalHealthMonth, 23andMe Product Scientist Becca Krock answered questions about our 23andMe+ Depression report (Powered by 23andMe Research).
Meet our new Chief Corporate Development Officer, Reza Afkhami, who will be responsible for spearheading and driving a wide range of industry collaborations for 23andMe. We chatted with him about his career, joining the #23andMeGenePool, and this new role. 📷: Jim Block
We’re looking for a Sr. Manager, Clinical Supply Chain to join our Therapeutics team! You will have the opportunity to manage Supply Chain-related activities around Pre-Clinical and Clinical Trial Material (PC/CTM) and Investigational Medical Product (IMP).
Mental health conditions affect more than 50 million people in the U.S. Just like your physical health, your emotional and mental health is imperative to quality of life and wellbeing. This month is all about empowering yourself and those around you in normalizing the discussion and bridging the gaps around mental health. #MentalHealthMonth #MHM Source: https://lnkd.in/ertMj3ZJ
This #LupusAwarenessMonth, learn more about lupus, a group of autoimmune conditions that can impact many parts of the body and disproportionately affects women of color. Our new 23andMe+ Lupus report (Powered by 23andMe Research) uses a statistical model that includes more than 1,900 genetic markers and information on ethnicity and sex assigned at birth to determine your likelihood of being diagnosed with the condition.
